生命科学资讯

Nvidia dives deeper into medtech, cancer research with Droplet Biosciences

ARPA-H launches $158M effort to aid first-ever lymphatic system medicines

Bayer tosses 1 Pompe gene therapy from $2B AskBio buyout to focus on alternative option

UK invests $64M to expand clinical trial access to underserved communities

Bayer continues trimming workforce; AnaptysBio's spinoff is named

BIO chief still backs FDA's Makary despite 'head-scratcher' decisions

Marc Casper sells 5,000 TMO shares via Fidelity (TMO) - Stock Titan

FDA again targets GLP-1 compounders; Intellia to restart heart disease trial

Why Illumina (ILMN) is a Top Growth Stock for the Long-Term - Nasdaq

Thermo Fisher Scientific Expands Immunodiagnostics Operations with New Distribution and Labeling Center in Uppsala - WebWire

10x Genomics $TXG Position Lifted by Vanguard Group Inc. - MarketBeat

Moderna to pay up to $2.25B to settle COVID-19 patents case

What 3 recent FDA rejections reveal about shifts inside the agency

Inside the race to thwart the dramatic rise in early-onset colorectal cancer

Sanofi licenses Sino Biopharm’s transplant drug for $135M upfront

Ono’s Deciphera drops early-stage solid tumor drug for strategic reasons

Teva bags $400M deal with Blackstone to fund Sanofi-partnered IBD drug

Picton Mahoney Asset Management Takes $17.01 Million Position in Thermo Fisher Scientific Inc. $TMO - MarketBeat

UCB boards T cell engager train in $60M upfront deal with Antengene

Blackstone to support Teva on Sanofi-partnered TL1A with $400M